Search

everythinglearnresearchcommunity

for

Search:↓

Genetic predictions of baldness in Europeans don't apply well to African men.

The document's conclusion can't be summarized because the text is not in English and the document content is not provided.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Baldness and shaved heads change how traits are seen but don't really affect leader preferences.

Pill splitting increased generic finasteride sales but didn't affect branded finasteride sales.

Higher doses of minoxidil may help women who don't respond to the standard treatment.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Trichocytic differentiation starts in cells with epithelial cytokeratins, transitioning to trichocytic cytokeratins in hair and gradually in nails.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Nonshaven follicular unit extraction is a good hair transplant option that doesn't require shaving and can transplant up to 3000 grafts daily.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Immune activities and specific genes are important in male pattern baldness.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Baldness may be linked to heart disease, but the evidence isn't strong enough to consider it a major risk factor.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

The study looked at how common male pattern baldness is in young men in a heart care unit but didn't give specific results.

Early onset hair loss is linked to low vitamin D, but severity isn't related to vitamin D levels.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

A scalp biopsy can help confirm hair loss types when other methods don't provide a clear diagnosis.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.